
Raycure Drugs Limited
About Raycure Drugs Limited
Data last updated:
Raycure Drugs Limited is a public limited company based in Chandigarh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 02 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U00304CH2006PLC029458. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Tarsem Kumar Ruby and Veeta Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 859 Nac Manimajra U.T. Chandigarh., Chandigarh, India.
As per the financials filed for FY 2017, the company reported a revenue of ₹45.18 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹25,129 (net margin -0.6%) and EBITDA of -₹22,362 (EBITDA margin -0.5%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Raycure Drugs Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 859 Nac Manimajra U.T. Chandigarh., Chandigarh, India
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Raycure Drugs Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Raycure Drugs Limited
FY 2025 filings availableRaycure Drugs Limited reported revenue of ₹45.18 Lakh (down 17% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 17% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹45.18 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹22,362 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹25,129 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -0.5% | ||
| Net Profit Margin | -0.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Raycure Drugs Limited, buy the company report.
Board of directors of Raycure Drugs Limited
Raycure Drugs has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarsem Kumar Ruby Also directs: Raymed Pharmaceuticals Limited, Raymed Ophthalmic Private Limited, Raymzon Trade Links Private Limited and 4 more | Director | 02 Jan 2006 | 20 Years 10 Months | Current |
| Veeta Sharma Also directs: Raymed Pharmaceuticals Limited, Raymzon Trade Links Private Limited, Raymazon Pharmalinks Private Limited and 1 more | Director | 02 Jan 2006 | 20 Years 10 Months | Current |
| Sanjay Jhamb Also directs: Raymed Ophthalmic Private Limited | Additional Director | 31 Aug 2020 | 6 Years 2 Months | Current |
Auditor
Raycure Drugs Limited is audited by ATUL CHOPRA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL CHOPRA & CO. | FY 2017 | 012289N |
Shareholding
The shareholding of Raycure Drugs Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Raycure Drugs Limited, buy the company report.
Legal cases
No court or tribunal cases involving Raycure Drugs Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raycure Drugs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raycure Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Raycure Drugs Limited, buy the company report.
Recent activity
Raycure Drugs Limited has 4 board changes on record since 2006: 3 appointments and 1 cessation. The latest: Sanjay Jhamb was appointed as Additional Director on 31 Aug 2020.
Frequently asked questions
Raycure Drugs is an active public limited company based in Chandigarh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 02 January 2006 (20+ years old) and is registered under CIN U00304CH2006PLC029458.
Raycure Drugs has 3 current directors:
- Tarsem Kumar Ruby - Director
- Veeta Sharma - Director
- Sanjay Jhamb - Additional Director
The latest financial statements of Raycure Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Raycure Drugs has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Raycure Drugs is U00304CH2006PLC029458. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raycure Drugs was incorporated on 02 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Chandigarh.
Sanjay Jhamb was appointed as Additional Director on 31 Aug 2020. Sat Parkash Mittal ceased to be Director on 31 Aug 2020. Tarsem Kumar Ruby was appointed as Director on 02 Jan 2006. Raycure Drugs has 4 board changes on record in total.
The registered office of Raycure Drugs is at SCO 859 Nac Manimajra U.T. Chandigarh., Chandigarh, India.
Raycure Drugs operates in the chemicals industry, in the chemical products segment.
The compliance status of Raycure Drugs is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.

